期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

内皮抑制因子抗肿瘤作用机制研究进展 被引量：2

下载PDF
导出
作者 朱晓红 闫鸿 臧树良
机构地区 解放军第二O二医院 华东师范大学化学系
出处 《中国公共卫生》 CAS CSCD 北大核心 2007年第8期1011-1013,共3页 Chinese Journal of Public Health
基金 辽宁省科技攻关重大项目(2001226001)
关键词 抗肿瘤作用机制 抑制因子 抑制肿瘤生长 内皮 恶性肿瘤 卫生事业 本质特性 新生血管
分类号 R979.5 [医药卫生—药品]
  • 相关文献

参考文献22

  • 1罗进,吴威.鞍山市1995～2000年恶性肿瘤发病分析[J].中国公共卫生,2004,20(6):715-715. 被引量：1
  • 2唐晓君,刘达伟,胡志琼.重庆市城市居民1991～2000年恶性肿瘤死因分析[J].中国公共卫生,2002,18(8):964-965. 被引量：15
  • 3贺宇彤,侯浚,乔翠云,陈志峰,宋国慧,孟凡书,李绍森,冀洪新,陈超.河北磁县1988～2002恶性肿瘤发病趋势分析[J].中国公共卫生,2005,21(3):302-303. 被引量：13
  • 4何中秋,张国棋,杨亚斌,李英辉,张晶.肿瘤血管生长因子抑制剂的研究[J].中国公共卫生,2003,19(6):705-706. 被引量：1
  • 5Rehn M,Veikkola T,Kukk Valdre E,et al.Interaction of endostatin with integrms impicated in angiogenesis[J].Proc Natl Acad Sci USA,2001,98(3):1024-1029.
  • 6Hanai J,Dhanabal M,Karumanchi SA,et al.Endostatm causesqarest of endo thelial cells through inhibition of eye lin D l[J].J Biol Chem,2002,277(19):16464-16469.
  • 7Ergun S,Kilic N,Wurmbach J H,et al.Endostatm inhibits angiogenesis by stabilization of newly formed endothelial tubes[J].Angiogenesis,2001,4(3):193-206.
  • 8Lee SJ,Jang JW,Kim YM,et al.Endostatin brads to the catalytic domain of matrix metalloproteinase-2[J].FEBS Lett,2002,519(123):147-1521.
  • 9Wickstrom SA,Veikkola T,Rehn M,et al.Endostatin mdused modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells[J].Cancer Res,2001,61 (17):6511-6516.
  • 10Mac Donald N J,Shivers W Y,Narum DL,et al.Endostain binds trupomyosin,a potential modulator of the antitumor activitity of endostatin[J].J Bio Chem,2001,276(27):25190-25196.

二级参考文献45

  • 1王声湧.死因分析与评价方法的进展[J].中华流行病学杂志,1996,17(4):239-242. 被引量：166
  • 2Sunasseek,vile R. Tumor angiogenesis: Hitting cancer where it hurts[J]. Current Biology, 1997,7 (2): 282-285.
  • 3O'Reilly MS,Boehm T,Shing Y,et al. Endostatin:an endogenous inhibitor of angiogenesis and tumor growth[J]. Cell, 1997,88(2) : 277.
  • 4Beohm T, Folkman J, Brmoder T,et al. Antigiogenis therapy of experimental cancer does not induce acquired drug resistance[J].Naterl , 1997,390(2) :404.
  • 5Rckwell P,O'Connor WJ,King K,et al. Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factorreceptors by phosphorothioute oligodeoxynucleotides[J]. Proc, Natl Acad Sci USA, 1997,94 (32): 6523.
  • 6O'Reilly MS, Boehm T. Shing Y,et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth[J]. Cell, 1997,88(2): 277-288.
  • 7Deane BR,antos PL. The vasculature of experimental brain tumors. 1＞A sepuential liaght and electron microscope study of angioensis[J]. J Neurol Sci,1981,49(1) :55.
  • 8Y eao.Endogenous angiogenesis inhibitors and their therapeutic implications.I nternat J Biochem & Cell Biol,2001,33:357-369.
  • 9O'keilly MS,Boem J,Shing Y,et al.Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.Cell,1997,88:277-285.
  • 10Sasaki T,Fukai N,Mann K,et al.Structure,function and tissue forms of the C-terminal globular domain of collagen ⅩⅧ containingthe angiogenesis inhibitor endostatin.EMBO J,1998,17: 4249-4256.

共引文献31

同被引文献27

  • 1Grivennikov SI, Greten FR, Karin M. Immunity, inflammation,and cancer[J].Cell,2010,140(6) :883 -899.
  • 2Hanahan D, Weinberg RA. Hallmarks of cancer : the next genera-tion [J]. Cell,2011,144:646 -674.
  • 3Patenaude A, Parker J, Karsan A. Involvement of endothelial pro-genitor cells in tumor vascularization [ J ]. Microvascular Re-search,2010,79(3) :217 -223.
  • 4Fang S,Salven P. Stem cells in tumor angiogenesis[ J]. Journalof Molecular and Cellular Cardiology ,2011 ,50(2) :290 -295.
  • 5Matsubara T,Kanto T,Kuroda S,et al. TIE2-expressing monocytesas a diagnostic marker for hepatocellular carcinoma correlates withangiogenesis[ J]. Hepatology,2013,57(4) :1416 -1425.
  • 6Favre J, Terborg N, Horrevoets AJG. The diverse identity of an-giogenic monocytes [ J ]. European Journal of Clinical Investiga-tion,2013,43( 1) :100 - 107.
  • 7Murdoch C,Tazzyman S, Webster S,et al. Expression of Tie-2by human monocytes and their responses to angiopoietin-2[ J].The Journal of Immunology ,2007,178(11) :7405 - 7411.
  • 8Daly C,Eichten A,Castanaro C,et al. Angiopoietin-2 functionsas a Tie2 agonist in tumor models,where it limits the effects ofVEGF inhibition[ J]. Cancer Research,2013,73 : 108 - 118.
  • 9Du R,Lu KV,Petritsch C,et al. HIF1 -a induces the recruitmentof bone marrow-derived vascular modulatory cells to regulatetumor angiogenesis and invasion [J]. Cancer Cell ,2008 ,13(3):206 -220.
  • 10Coffelt SB, Tal AO, Scholz A, et al. Angiopoietin-2 regulatesgene expression in TIE2-expressing monocytes and augmentstheir inherent proangiogenic functions [ J ]. Cancer Research,2010,70(13):5270 -5280.

引证文献2

二级引证文献3

中国公共卫生
2007年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部